Back to News
Market Impact: 0.3
Bayer to Invest $2.2 Billion in a New Manufacturing Site in Ohio
Source: GlobeNewswire
Healthcare & BiotechCompany FundamentalsInfrastructure & Defense
Bayer plans to invest $2.2 billion to build a new pharmaceutical manufacturing facility in New Albany, Ohio. The project, announced with Ohio Governor Mike DeWine and JobsOhio, signals a significant expansion of Bayer's U.S. production footprint and regional manufacturing investment.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment
BAYN0.85
More News
- Bayer to invest $2.2 billion in new Ohio manufacturing site
- Anthropic warns government attitudes may hurt customer ties, IPO prospectus shows: Reuters
- New aircraft carrier, 10,000 US troops: Is the Iran war about to escalate?
- U.S. to send third carrier group to Mideast as Trump warns of new Iran strikes
- US Adds Carrier and 10,000 Troops to Mideast
- Your health insurance premiums may take a big jump in 2027 — here's why
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Index and ETF Holdings Data for AI Research
- Capital Intensity as Gravity: The AI Trade Enters Its Industrial Era (Looking at Q3 2025 Earnings in Tech)